The potential for CETP inhibition to reduce cardiovascular disease risk

Author： Ansell Benjamin Hobbs F. D. Richard

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.12, 2006-12, pp. : 2467-2478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Signatures of Cardiovascular Disease Risk: Potential for Test Development and Clinical Application

By Schunkert Heribert

Molecular Diagnosis & Therapy, Vol. 12, Iss. 5, 2008-01 ,pp. : 281-287

Adis International

Access to resources Recommend Favorite

Target intervention against multiple‐risk markers to reduce cardiovascular disease in patients with type 2 diabetes

By Gæde Peter Pedersen Oluf

Annals of Medicine, Vol. 36, Iss. 5, 2004-09 ,pp. : 355-366

Informa Healthcare

Access to resources Recommend Favorite

Metformin and Risk of Cardiovascular Disease

Cardiology, Vol. 91, Iss. 3, 1999-09 ,pp. : 203-204

Karger

Access to resources Recommend Favorite

Value of a facilitated quality improvement initiative on cardiovascular disease risk: findings from an evaluation of the Aggressively Treating Global Cardiometabolic Risk Factors to Reduce Cardiovascular Events (AT GOAL)

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 21, Iss. 5, 2015-10 ,pp. : 963-970

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic potential of midkine in cardiovascular disease

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 171, Iss. 4, 2014-02 ,pp. : 936-944

John Wiley & Sons Inc

Access to resources Recommend Favorite